Should I buy or sell Inspira Technologies Oxy B.H.N. stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inspira Technologies Oxy B.H.N. in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" IINN shares. View IINN analyst ratings or view top-rated stocks .

What is Inspira Technologies Oxy B.H.N.'s stock price target for 2024?

1 brokers have issued 12-month price targets for Inspira Technologies Oxy B.H.N.'s stock. Their IINN share price targets range from $13.00 to $13.00. On average, they anticipate the company's share price to reach $13.00 in the next year. This suggests a possible upside of 1,115.0% from the stock's current price. View analysts price targets for IINN or view top-rated stocks among Wall Street analysts .

How have IINN shares performed in 2023?

Inspira Technologies Oxy B.H.N.'s stock was trading at $1.29 on January 1st, 2023. Since then, IINN shares have decreased by 17.1% and is now trading at $1.07. View the best growth stocks for 2023 here .

Are investors shorting Inspira Technologies Oxy B.H.N.?

Inspira Technologies Oxy B.H.N. saw a increase in short interest in November. As of November 15th, there was short interest totaling 8,200 shares, an increase of 141.2% from the October 31st total of 3,400 shares. Based on an average daily volume of 22,100 shares, the short-interest ratio is currently 0.4 days. Currently, 0.1% of the shares of the stock are short sold. View Inspira Technologies Oxy B.H.N.'s Short Interest .

When did Inspira Technologies Oxy B.H.N. IPO?

(IINN) raised $19 million in an initial public offering (IPO) on Wednesday, July 14th 2021. The company issued 2,909,091 shares at a price of $5.50-$7.50 per share.

How do I buy shares of Inspira Technologies Oxy B.H.N.?

Shares of IINN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Inspira Technologies Oxy B.H.N. Stock Price, News & Analysis (NASDAQ:IINN)

$1.06

-0.04 (-3.20%)

(As of 03:51 PM ET)

Compare

Today's Range: $1.05
▼
$1.13
50-Day Range: $1.02
▼
$1.52
52-Week Range: $0.98
▼
$1.99

Volume: 38,021 shs
Average Volume: 42,845 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $13.00

Inspira Technologies Oxy B.H.N. MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 1,115.0% Upside
$13.00 Price Target
Short Interest: Healthy
0.13% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.98
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($1.18) to ($0.70) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.27 out of 5 stars

3.5

Analyst's Opinion

Consensus Rating
Inspira Technologies Oxy B.H.N. has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $13.00, Inspira Technologies Oxy B.H.N. has a forecasted upside of 1,115.0% from its current price of $1.07.
Amount of Analyst Coverage
Inspira Technologies Oxy B.H.N. has received no research coverage in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
0.13% of the float of Inspira Technologies Oxy B.H.N. has been sold short.
Short Interest Ratio / Days to Cover
Inspira Technologies Oxy B.H.N. has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Inspira Technologies Oxy B.H.N. has recently increased by 141.18%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Inspira Technologies Oxy B.H.N. does not currently pay a dividend.
Dividend Growth
Inspira Technologies Oxy B.H.N. does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for IINN.

2.8

News and Social Media Coverage

News Sentiment
Inspira Technologies Oxy B.H.N. has a news sentiment score of 0.98. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for Inspira Technologies Oxy B.H.N. this week, compared to 0 articles on an average week.
Search Interest
Only 1 people have searched for IINN on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Inspira Technologies Oxy B.H.N. insiders have not sold or bought any company stock.
Percentage Held by Insiders
29.40% of the stock of Inspira Technologies Oxy B.H.N. is held by insiders. A high percentage of insider ownership can be a sign of company health.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Inspira Technologies Oxy B.H.N. are expected to grow in the coming year, from ($1.18) to ($0.70) per share.
Price to Book Value per Share Ratio
Inspira Technologies Oxy B.H.N. has a P/B Ratio of 0.65. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Inspira Technologies Oxy B.H.N. Stock (NASDAQ:IINN)

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.

IINN Stock Price History

30 days | 90 days | 365 days | Advanced Chart

IINN Stock News Headlines

November 30, 2023 | finance.yahoo.com

Inspira (IINN) Expands in Life Support Space With New Deal

November 29, 2023 | finance.yahoo.com

Inspira Collaborates with Ennocure for development of a Proprietary Bio-Electronic Treatment to Prevent Associated Bloodstream Infections in ICU Patients

December 5, 2023 | Financial Alphas (Ad)

Countries Are Investing Heavily Into Securing Energy Independence

There's a worldwide "arms race" for countries to secure lithium - the critical metal essential to powering the world's green energy transition. While the U.S. is now investing heavily into lithium production, the North American supply chain has fallen far behind. One company is on a mission to change that and make a previously remote area the next great lithium mining hub.

November 16, 2023 | msn.com

Inspira Technologies Oxy B.H.N. reports 9M results

November 16, 2023 | finanznachrichten.de

Inspira Technologies Reports Third Quarter 2023 Financial Results

November 16, 2023 | finance.yahoo.com

Inspira™ Technologies Reports Third Quarter 2023 Financial Results

November 6, 2023 | finance.yahoo.com

Inspira™ Announces Israeli Innovation Authority Grant for New VORTX™ Disposable Blood Oxygenation Technology

October 25, 2023 | finance.yahoo.com

Inspira™ Granted U.S. Patent for INSPIRA™ ART500 Medical Device

December 5, 2023 | Financial Alphas (Ad)

Countries Are Investing Heavily Into Securing Energy Independence

October 24, 2023 | msn.com

Inspira Technologies terminates its at-the-market equity offering

October 24, 2023 | finance.yahoo.com

Inspira™ Terminates ATM Program and Provides an Update

October 11, 2023 | money.usnews.com

Inspira Technologies Oxy B.H.N. Ltd

October 10, 2023 | finance.yahoo.com

Inspira™ Enters into a Distribution Agreement in Central America with CIO MED GROUP

September 28, 2023 | finance.yahoo.com

Inspira™ Technologies Unveils the INSPIRA™ ART Line of Medical Devices at the World's Largest Extracorporeal Life Support Conference

September 13, 2023 | finance.yahoo.com

Inspira™ Announces 510(k) FDA Submission of INSPIRA™ ART100 Towards Commercialization

August 31, 2023 | finance.yahoo.com

Inspira (IINN) Advances Foothold in Europe With Extended Deal

August 29, 2023 | finance.yahoo.com

Inspira™ Signs Agreement Expansion with Innovimed for Clinical Trials of INSPIRA™ ART Respiratory Medical Devices

August 11, 2023 | msn.com

Inspira Technologies Oxy B.H.N. reports Q2 results

August 10, 2023 | finanznachrichten.de

Inspira Technologies Reports Second Quarter 2023 Financial Results

August 10, 2023 | finance.yahoo.com

Inspira™ Technologies Reports Second Quarter 2023 Financial Results

August 9, 2023 | finance.yahoo.com

INSPIRA™ ART100 Completes Usability Study in Boston Massachusetts, U.S.

July 24, 2023 | finance.yahoo.com

Inspira™ Technologies Receives Certification of Medical Devices Quality Management Systems, Another Step Towards EU Regulatory Approval

July 19, 2023 | finance.yahoo.com

Inspira™ Technologies Enters into Collaboration Agreement with U.S.-Based Perfusion Solution Inc.

June 15, 2023 | finance.yahoo.com

Inspira™ Technologies Unveils Investor Deck Showcasing Revolutionary Advancement in Acute Respiratory Care

May 30, 2023 | finance.yahoo.com

Inspira Technologies Appoints Dr. Nir as Chief Medical Officer

May 18, 2023 | finanznachrichten.de

Inspira Technologies Reports First Quarter 2023 Financial Results

May 18, 2023 | finance.yahoo.com

Inspira™ Technologies Reports First Quarter 2023 Financial Results

See More Headlines

Receive IINN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inspira Technologies Oxy B.H.N. and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 12/05/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:IINN
CUSIP: N/A
CIK: 1837493
Web: inspira-technologies.com
Phone: 972-4623-0333
Fax: N/A
Employees: 32
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $13.00
High Stock Price Target: $13.00
Low Stock Price Target: $13.00
Potential Upside/Downside: +1,115.0%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-10,270,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -128.07%
Return on Assets: -94.22%

Debt

Debt-to-Equity Ratio: 0.18
Current Ratio: 3.34
Quick Ratio: 3.34

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.64 per share
Price / Book: 0.65

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 1.90

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

Mr. Dagi Shahar Ben-Noon (Age 47)
Co-Founder, CEO & Director
Comp: $369.43k
Mr. Joe Hayon (Age 49)
Co-Founder, President & Director
Comp: $384.1k
Ms. Yafit Tehila (Age 41)
CFO and Principle Financial & Accounting Officer
Comp: $265.04k
Mr. Avi Shabtai (Age 49)
COO and VP of Research & Development
Comp: $310.42k
Ms. Daniella Yeheskely-Hayon Ph.D. (Age 47)
Chief Technology Officer
Comp: $237.87k
Meshira Greenberg
Administrative Manager
Adi Shmueli
Marketing & Communications Manager
Odelya Ben-Asher Dekel
Human Resources Manager
Ms. Adi Rizansky Nir Ph.D.
Chief Medical Officer

Key Competitors

View All Competitors

IINN Stock Analysis - Frequently Asked Questions

Should I buy or sell Inspira Technologies Oxy B.H.N. stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inspira Technologies Oxy B.H.N. in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" IINN shares.
View IINN analyst ratings or view top-rated stocks.
What is Inspira Technologies Oxy B.H.N.'s stock price target for 2024?: 1 brokers have issued 12-month price targets for Inspira Technologies Oxy B.H.N.'s stock. Their IINN share price targets range from $13.00 to $13.00. On average, they anticipate the company's share price to reach $13.00 in the next year. This suggests a possible upside of 1,115.0% from the stock's current price.
View analysts price targets for IINN or view top-rated stocks among Wall Street analysts.
How have IINN shares performed in 2023?: Inspira Technologies Oxy B.H.N.'s stock was trading at $1.29 on January 1st, 2023. Since then, IINN shares have decreased by 17.1% and is now trading at $1.07.
View the best growth stocks for 2023 here.
Are investors shorting Inspira Technologies Oxy B.H.N.?: Inspira Technologies Oxy B.H.N. saw a increase in short interest in November. As of November 15th, there was short interest totaling 8,200 shares, an increase of 141.2% from the October 31st total of 3,400 shares. Based on an average daily volume of 22,100 shares, the short-interest ratio is currently 0.4 days. Currently, 0.1% of the shares of the stock are short sold.
View Inspira Technologies Oxy B.H.N.'s Short Interest.

When did Inspira Technologies Oxy B.H.N. IPO?: (IINN) raised $19 million in an initial public offering (IPO) on Wednesday, July 14th 2021. The company issued 2,909,091 shares at a price of $5.50-$7.50 per share.
How do I buy shares of Inspira Technologies Oxy B.H.N.?: Shares of IINN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:IINN) was last updated on 12/5/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial